Brain Metastases Status and Immunotherapy Efficacy in Advanced Lung Cancer: A Systematic Review and Meta-Analysis

BACKGROUND: Brain metastases (BMs) indicate poor outcomes and are commonly excluded in immunotherapy clinical trials in advanced lung cancer; moreover, the effect of BM status on immunotherapy efficacy is inconsistent and inconclusive. Therefore, we conducted a meta-analysis to assess the influence...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Hao, Xu, Zhi-Yong, Zhu, Qian, Liu, Xi, Jiang, Si-Cong, Zheng, Ji-Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8316922/
https://www.ncbi.nlm.nih.gov/pubmed/34335570
http://dx.doi.org/10.3389/fimmu.2021.669398

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8316922/
https://www.ncbi.nlm.nih.gov/pubmed/34335570
http://dx.doi.org/10.3389/fimmu.2021.669398

Ejemplares similares